HUT67577A - Process for production of adsorbate comprising adjuvant-mixture and non-solid active agent using production of preparations - Google Patents

Process for production of adsorbate comprising adjuvant-mixture and non-solid active agent using production of preparations Download PDF

Info

Publication number
HUT67577A
HUT67577A HU9302555A HU9302555A HUT67577A HU T67577 A HUT67577 A HU T67577A HU 9302555 A HU9302555 A HU 9302555A HU 9302555 A HU9302555 A HU 9302555A HU T67577 A HUT67577 A HU T67577A
Authority
HU
Hungary
Prior art keywords
adsorbate
production
mixture
active ingredient
hoe
Prior art date
Application number
HU9302555A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9302555D0 (en
Inventor
Theophil Hornykiewytsch
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HU9302555D0 publication Critical patent/HU9302555D0/hu
Publication of HUT67577A publication Critical patent/HUT67577A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU9302555A 1992-09-11 1993-09-09 Process for production of adsorbate comprising adjuvant-mixture and non-solid active agent using production of preparations HUT67577A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4230371 1992-09-11

Publications (2)

Publication Number Publication Date
HU9302555D0 HU9302555D0 (en) 1993-11-29
HUT67577A true HUT67577A (en) 1995-04-28

Family

ID=6467712

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9302555A HUT67577A (en) 1992-09-11 1993-09-09 Process for production of adsorbate comprising adjuvant-mixture and non-solid active agent using production of preparations

Country Status (13)

Country Link
EP (1) EP0587137A1 (index.php)
JP (1) JPH06192093A (index.php)
KR (1) KR940006583A (index.php)
AU (1) AU663000B2 (index.php)
CA (1) CA2105913A1 (index.php)
FI (1) FI933954L (index.php)
HU (1) HUT67577A (index.php)
IL (1) IL106953A0 (index.php)
MX (1) MX9305578A (index.php)
NO (1) NO933237L (index.php)
NZ (1) NZ248627A (index.php)
TW (1) TW222585B (index.php)
ZA (1) ZA936695B (index.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ267002A (en) * 1993-06-04 1997-07-27 Warner Lambert Co Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
BR9916361A (pt) * 1998-12-18 2002-11-05 Abbott Lab Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
EP1765297A2 (en) * 2004-06-28 2007-03-28 LifeCycle Pharma A/S Porous tablets as carriers for liquid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
EP0587137A1 (de) 1994-03-16
NO933237D0 (no) 1993-09-10
HU9302555D0 (en) 1993-11-29
FI933954A7 (fi) 1994-03-12
TW222585B (index.php) 1994-04-21
MX9305578A (es) 1994-03-31
NO933237L (no) 1994-03-14
IL106953A0 (en) 1993-12-28
KR940006583A (ko) 1994-04-25
FI933954L (fi) 1994-03-12
AU4626293A (en) 1994-03-17
JPH06192093A (ja) 1994-07-12
AU663000B2 (en) 1995-09-21
FI933954A0 (fi) 1993-09-09
ZA936695B (en) 1994-04-05
NZ248627A (en) 1995-01-27
CA2105913A1 (en) 1994-03-12

Similar Documents

Publication Publication Date Title
JP7642149B2 (ja) 新たな医薬組成物
CN1630510B (zh) 药物形式的阿托伐他汀钙、其组合物和包含阿托伐他汀钙的药物制剂
EP2331074B1 (en) Granulates, process for preparing them and pharmaceutical products containing them
CZ20021765A3 (cs) Způsob potahování jader tablet a tablety tímto způsobem získané
CA2584547C (en) Solid pharmaceutical composition comprising donepezil hydrochloride
KR0170380B1 (ko) 고상 투여형용 안정화계
NO303669B1 (no) FremgangsmÕte for fremstilling av en tablett eller dragÚpreparat
JP3786287B2 (ja) 塩酸ベニジピン含有医薬組成物
JP4293572B2 (ja) ロキソプロフェン・ナトリウム含有錠剤
HUT67577A (en) Process for production of adsorbate comprising adjuvant-mixture and non-solid active agent using production of preparations
JPH1121236A (ja) ロキソプロフェン・ナトリウム固形製剤
JPH09124480A (ja) ビタミン製剤
CZ287149B6 (en) Pharmaceutical preparation containing gemfibrozil
JP2000016940A (ja) ビタミンｂ▲１２▼類含有組成物
EP4337175A1 (en) Pharmaceutical formulation of valsartan and sacubitril
US20090048336A1 (en) Escitalopram oxalate powders
JPH09100229A (ja) ロキソプロフェン・ナトリウム含有固形製剤
JP6233911B2 (ja) 化学的な安定性が向上したイルベサルタン含有錠剤
JP2021134168A (ja) 固形製剤及びその製造方法
AU2016202063B2 (en) Novel pharmaceutical composition
JP6199922B2 (ja) 化学的な安定性が向上したイルベサルタン含有錠剤
JP2011126857A (ja) パロキセチン塩酸塩含有経口用錠剤
RU2188019C1 (ru) Фармацевтическая композиция, обладающая противогрибковой активностью, и способ ее получения
JP2002226371A (ja) プラバスタチンナトリウムの錠剤
JP2018009032A (ja) 化学的な安定性が向上したイルベサルタン含有錠剤

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal